Ben joined the Group as a Senior Analyst for the Capital Markets Research Team in 2008 after working as an Equity Analyst on the sell side at Emerging Growth Capital, Australia.  Ben has also lived in Singapore where he held the position of Technology Investment Advisory at Asia-Pacific BioVentures.

Ben brings a wealth of knowledge to his role and holds a Masters of Applied Finance as well as a PhD in Genetic and Bioinformatics at The Walter and Eliza Hall Institute of Medical Research from the University of Melbourne.

Ben plays an important role in developing the scenarios analysis models and enhancing MLC’s stochastic modelling processes.